You are here » Home » Companies » Company Overview » Caplin Point Laboratories Ltd

Caplin Point Laboratories Ltd.

BSE: 524742 Sector: Health care
NSE: CAPLIPOINT ISIN Code: INE475E01026
BSE LIVE 12:24 | 18 Oct 694.00 -1.35
(-0.19%)
OPEN

696.00

HIGH

707.65

LOW

694.00

NSE 12:08 | 18 Oct 697.70 -0.20
(-0.03%)
OPEN

696.55

HIGH

706.75

LOW

694.85

OPEN 696.00
PREVIOUS CLOSE 695.35
VOLUME 1549
52-Week high 783.90
52-Week low 284.00
P/E 64.98
Mkt Cap.(Rs cr) 5,247
Buy Price 693.05
Buy Qty 20.00
Sell Price 694.00
Sell Qty 72.00
OPEN 696.00
CLOSE 695.35
VOLUME 1549
52-Week high 783.90
52-Week low 284.00
P/E 64.98
Mkt Cap.(Rs cr) 5,247
Buy Price 693.05
Buy Qty 20.00
Sell Price 694.00
Sell Qty 72.00

Caplin Point Laboratories Ltd. (CAPLIPOINT) - Company History

Incorporated in Apr.'90, Caplin Point Laboratories was promoted by P C Partheeban, T Palanisamy, S Karunakaran, S Jayaraman and B A Ahmed. The company manufactures pharmaceutical formulations in the form of tablets, ointments and capsules, liquid orals and oral powders. The company came out with a public issue in Nov.'94 and expanded its production capacity by setting up a new unit to manufacture its range of products, at Pondicherry. The company has retained its SSI status even after the expansion and thus will be out of the purview of the DPCO. During 1993-94, Triwin (a partnership firm) was merged with Caplin Point. The company entered into a technical agreement with American Remedies, US, and Concord Laboratories, US, for specific products, with a 30% buyback arrangement. It also imports bio-technological products to market them in India. The company has established a trading branch in Nairobi, Kenya, to sell its products in East Africa. It has also established a warehouse in Miami, US, by entering into a marketing tie-up with Lockett Medical Corporation, US.